NON-COMPLIANCE WITH ARTHRITIS DRUGS - MAGNITUDE, CORRELATES, AND CLINICAL IMPLICATIONS
- 1 January 1981
- journal article
- research article
- Vol. 8 (6) , 931-936
Abstract
Objective information on arthritis drug compliance in usual care settings is sparse. Of causes of poor compliance, regimen complexity has received special attention. A previously validated pharmacy-based compliance measure was used to study compliance in an arthritis clinic. Across drugs, mean compliance was low (64%). Wide variations were seen among drugs, ranging from 55% mean compliance (indomethacin) to > 80% (prednisone, penicillamine). Major variations by diagnosis were found, with rheumatoid arthritis patients more compliant than others. Regimen complexity was a relatively weak correlate of compliance, and the overall level of arthritis drug compliance was similar to that reported for antihypertensive drugs.This publication has 3 references indexed in Scilit:
- IbuprofenAnnals of Internal Medicine, 1979
- Drug Compliance in Outpatients with Rheumatoid ArthritisAustralian and New Zealand Journal of Medicine, 1979
- Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.Annals of the Rheumatic Diseases, 1967